Department of Dermatology

Semi-Automatic Cell Correspondence Analysis Using Iterative Point Cloud Registration (2019) Chen S, Gehrer S, Kaliman S, Ravikumar N, Becit A, Aliee M, Dudziak D, et al. Conference contribution Rhinophyma-Like Cutaneous Leishmaniasis due to Leishmania aethiopica Treated Successfully with Liposomal Amphotericin B (2019) Kirchberger MC, Schliep S, Bogdan C Journal article, Editorial Myositis and neuromuscular side-effects induced by immune checkpoint inhibitors (2019) Moreira A, Loquai C, Pfoefer C, Kaehler KC, Knauss S, Heppt MV, Gutzmer R, et al. Journal article Corrigendum to "Antibody-based immunotherapy of acyclovir resistant ocular herpes simplex virus infection" [Virology 512 (2017) 194-200] (2019) Bauer D, Keller J, Alt M, Schubert A, Aufderhorst UW, Palapys V, Kasper M, et al. Journal article, Erratum PU.1 controls fibroblast polarization and tissue fibrosis (2019) Wohlfahrt T, Rauber S, Uebe S, Luber M, Soare A, Ekici AB, Weber S, et al. Journal article A gene regulatory architecture that controls region-independent dynamics of oligodendrocyte differentiation (2019) Cantone M, Küspert M, Reiprich S, Lai X, Eberhardt M, Göttle P, Beyer F, et al. Journal article, Original article Functionalization of T lymphocytes for magnetically controlled immune therapy: Selection of suitable superparamagnetic iron oxide nanoparticles (2019) Mühlberger M, Janko C, Unterweger H, Schreiber E, Band J, Lehmann C, Dudziak D, et al. Journal article, Original article Centrosomal protein TRIM43 restricts herpesvirus infection by regulating nuclear lamina integrity (2019) Full F, Van Gent M, Sparrer KMJ, Chiang C, Zurenski MA, Scherer M, Brockmeyer NH, et al. Journal article Phase I dose-escalation and expansion study of intratumoral CV8102, a RNA-based TLR- nd RIG-1 agonist in patients with advanced solid tumors (2018) Terheyden P, Weishaupt C, Heinzerling L, Klinkhardt U, Krauss J, Mohr P, Kiecker F, et al. Conference contribution The siRNA-mediated downregulation of PD-1 alone or simultaneously with CTLA-4 shows enhanced in vitro CAR-T-cell functionality for further clinical development towards the potential use in immunotherapy of melanoma (2018) Simon B, Harrer DC, Schuler-Thurner B, Schaft N, Schuler G, Dörrie J, Uslu U Journal article